Screener
Krystal Biotech, Inc. KRYS Cost of goods sold
Cost of goods sold at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept krys:CostOfGoodsAndServicesSoldOperating.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
| (in thousands, except per share data) | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Product revenue, net | $116,357 | $88,183 |
| Operating expenses | ||
| Cost of goods sold | 6,323 | 5,028 |
| Research and development | 15,331 | 14,256 |
| Selling, general and administrative | 41,014 | 32,647 |
| Total operating expenses | 62,668 | 51,931 |
| Income from operations | 53,689 | 36,252 |
| Other income |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Krystal Biotech, Inc.'s cost of goods sold?
- Krystal Biotech, Inc. (KRYS) reported cost of goods sold of $6.32M in Q1 2026.
- How has Krystal Biotech, Inc.'s cost of goods sold changed year-over-year?
- Krystal Biotech, Inc.'s cost of goods sold increased by 25.8% year-over-year, from $5.03M to $6.32M.
- What does cost of goods sold mean?
- Cost of goods sold represents the direct costs attributable to the production of the goods or services sold by the company. It includes raw materials, direct labor, and manufacturing overhead directly linked to revenue generation. Monitoring this metric is essential for assessing production efficiency and gross margin health.
Ask your AI about Krystal Biotech, Inc.'s cost of goods sold.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude